Table 2 Colostomy-related HSUVs

SG

With colostomy 0.915

Without colostomy 0.804

Boyd^a [35]

TTO

[20 years with CRC; 20 years with a colostomy]

Unscreened [0.80; 0.80]

Screened [0.80; 0.75]

Enrolled in a COL screening program [0.85; 0.79]

CRC patients [0.83; 0.90]

Dominitz [5]

EQ-5D

With stoma 0.836

Without stoma 0.870

Hamashima [40]

SF-6D

With stoma 0.69

Without stoma 0.73

Hornbrook [6]

SG

Stage II/III rectal cancer, permanent colostomy 0.50

Stage IV metastatic/unresectable disease without colostomy 0.25

State IV metastatic/unresectable disease with colostomy 0.25

Ness [8]

TTO

Currently with colostomy 0.84

Reversed colostomy 0.64

Community members 0.63

Smith [12]

EQ-5D

PRT and TME PS 0.823

TME PS 0.853

van den Brink [27]

SG

Stage II/III RC treated with resection, chemotherapy, radiation therapy and with permanent ostomy 0.50

Ness [8]